Note 2: Scope of consolidation

Material subsidiaries

The Consolidated financial statements comprise the assets, liabilities, income and expenses of approximately 283 legal entities (including the entities reported as held for sale). We consider legal entities material when they represent, for at least two subsequent years, more than 5% of either revenue or (before ) or based on qualitative aspects. Material subsidiaries included in the table below are 100% owned at year-end 2018.

Material subsidiaries related to continuing operations

Legal entity

Principal place of business/country of corporation

Akzo Nobel Coatings Inc.

United States

Akzo Nobel Swire Paints (Shanghai) Ltd.

China

Imperial Chemical Industries Limited

United Kingdom

International Paint LLC

United States

Akzo Nobel Coatings SPA

Italy

Acquisitions

On October 1, 2018, we acquired Fabryo Corporation S.R.L. (Fabryo) in Romania. The transaction includes two production facilities and six distribution centers for decorative paints, adhesives and mortars, including one of the largest decorative paints factories in the region, with capacity for further expansion. The business generated revenue of around €45 million in 2017 and is the only player with both a leading product portfolio for consumers as well as professional segments in the Romanian market, including brands Savana, APLA and InnenWeiss. In 2018, we performed a preliminary purchase price allocation. The goodwill is fully allocated to business unit Decorative Paints Europe, Middle East and Africa.

In 2018, other smaller acquisitions included Doves Decorating Supplies in the United Kingdom, Xylazel S.A. in Spain and Colourland Paints Sdn Bhd and Colourland Paints (Marketing) Sdn Bhd in Malaysia.

Recognized fair values at acquisition

In € millions

Acquisitions 2018

Other intangibles

59

Property, plant and equipment

27

Associates and joint ventures

3

Inventories

21

Trade and other receivables

47

Cash and cash equivalents

5

Long-term debt

(20)

Provisions

(1)

Deferred tax assets/(liabilities)

(9)

Trade and other payables

(37)

Net identifiable assets and liabilities

95

Goodwill

42

Purchase consideration

137

Cash and cash equivalents acquired

(5)

To be paid in 2019 and later years

(4)

Net cash outflow

128

The aggregated outcome of the preliminary purchase price allocations performed in 2018 is represented in the table above.

In December 2018, we also acquired the non-controlling interests from Swire Industrial Limited in several Akzo Nobel Swire Paints subsidiaries for €407 million. The goodwill on this transaction of €208 million was charged directly to shareholders’ equity.

In 2017, the acquisitions included Disa Technology (Disatech), Flexcrete Technologies Ltd and the business of V.Powdertech Co., Ltd.

Divestments

In April 2017, AkzoNobel announced its decision to separate the Specialty Chemicals business, thereby creating two focused, high performing businesses – Paints and Coatings, and Specialty Chemicals. At the Extraordinary General Meeting on November 30, 2017, the shareholders approved the proposed separation of the Specialty Chemicals business from AkzoNobel through a private sale or a legal demerger.

As from December 22, 2017, the Specialty Chemicals business is classified as held for sale and discontinued operations, therefore the Consolidated statement of income and the Consolidated statement of cash flows show the results of the Specialty Chemicals business as discontinued. The Specialty Chemicals business presented as held for sale and discontinued operations consists of the former Business Area Specialty Chemicals and assets, liabilities, income and expenses which are directly attributed to the Specialty Chemicals business, previously included in Corporate and Other, which are not recognized on an ongoing basis by AkzoNobel. The sale of the Specialty Chemicals business to the Carlyle Group and GIC for an enterprise value of €10.1 billion was completed on October 1, 2018. The difference of €8.3 billion with the consideration for the shares of €10.1 billion consists of settlement of , provisions and working capital as included in the closing balance sheet. The Specialty Chemicals business is now called Nouryon.

At year end 2018, AkzoNobel made a best estimate of the expected deal proceeds for the sale of the Specialty Chemicals business, including the net debt/working capital settlement that will be finalized in 2019.

In 2017 and 2018, otherwise no other significant divestments occurred.

Discontinued operations and held for sale

The results and cash flows from discontinued operations in 2017 as well as 2018 and the assets and liabilities held for sale at December 31, 2017 almost completely relate to the Specialty Chemicals business.

The income and expenses included in Held for sale effects and other mainly relate to the impact of ceasing of depreciation and amortization, partly offset by the related impact on inventory valuation, following IFRS 5 Assets held for sale accounting, as well as seperation costs.

Cash and cash equivalents as well as debt positions of Specialty Chemicals were excluded from held for sale classification unless such items were specifically designated as held for sale, e.g. in the case of specific local financing and debt related to finance leases held in relation to the Specialty Chemicals assets. The assets and liabilities of the Specialty Chemicals business are recognized at their carrying value.

Discontinued operations

In € millions

2017

2018*

*

2018 represents 9 months

Revenue

4,963

3,791

Expenses

(4,402)

(3,158)

Profit before tax

561

633

Income tax

(168)

(168)

Profit for the period after tax

393

465

Results related to discontinued
operations in previous years

1

(2)

Tax related to discontinued operations in previous years

(1)

Profit for the period

393

463

Gain on the sale of the
Specialty Chemicals business

6,074

Income tax on the sale

(263)

Total profit for the period from discon­tinued oper­ations

393

6,274

 

Revenue from third parties

Group revenue

Amorti­zation and depreciation

Identified items

Operating income

ROS%

In € millions

2017

20181

2017

20181

2017

20181

2017

20181

2017

20181

2017

20181

1

The Specialty Chemicals business was sold per October 1, 2018.

2

Held for sale effects and other include the impact of ceasing depreciation and amortization and the related impact on inventory evaluation following IFRS 5 Assets held for sale and separation costs.

Specialty Chemicals

4,961

3,791

4,985

3,809

(340)

(250)

18

625

470

12.2

12.3

Held for sale effects and other2

2

(22)

(18)

9

250

(67)

(29)

(54)

178

Total

4,963

3,791

4,963

3,791

(331)

(49)

(29)

571

648

12.5

17.1

Deal result

In € millions

2018

*

Excluding deal cost incurred in 2017.

Consideration for shares sold

8,284

Net assets and liabilities

(2,112)

Liabilities assumed and cost* allocated to the deal, realization of cumulative translation and cash flow hedge reserves

(98)

Income tax on the sale

(263)

Deal result after tax

5,811

Cash flows from discontinued operations

In € millions

2017

2018

*

Including the cash inflow from the divestment of €9,321 million.

Net cash from operating activities

691

351

Net cash from investing activities

(354)

8,723*

Results from financing activities

323

(116)

Cashflows from discon­tinued oper­ations

660

8,958

Cash inflow from divestment

In € millions

2018

Consideration for shares sold

8,284

Repayment of intercompany loan indebtedness

1,037

Total cash inflow

9,321

Balance sheet at divestment date

In € millions

2018

Intangible assets

796

Property, plant and equipment

2,490

Financial non-current assets

253

Inventories

540

Other current assets

283

Non-current liabilities

(792)

Short-term borrowings

(232)

Other current liabilities

(1,226)

Net assets and liabilities

2,112

Assets and liabilities held for sale

In € millions

2017

2018

Intangible assets

787

Property, plant and equipment

2,266

Financial non-current assets

205

Inventories

503

Receivables

840

Assets held for sale

4,601

Non-current liabilities

765

Short-term borrowings

341

Current payables

1,090

Liabilities held for sale

2,196

Employees

The average number of employees of the Specialty Chemicals business up to September 30, 2018 was 9,600 (full year 2017: 9,700). At September 30, 2018, the Specialty Chemicals business employed 9,900 people (December 31, 2017: 9,900).

Operating income

Operating income is defined in accordance with IFRS and includes the identified items to the extent these relate to lines included in operating income.

Identified items

Identified items are special charges and benefits, results on acquisitions and divestments, major restructuring and impairment charges and charges and benefits related to major legal, anti-trust, environmental and tax cases.

Net debt

Defined as long-term borrowings plus short-term borrowings less cash and cash equivalents and short-term investments.